This protocol describes a standard method for simultaneous functional magnetic resonance imaging and deep brain stimulation in the rodent. The combined use of these experimental tools allows for the exploration of global downstream activity in response to electrical stimulation at virtually any brain target.
In order to visualize the global and downstream neuronal responses to deep brain stimulation (DBS) at various targets, we have developed a protocol for using blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) to image rodents with simultaneous DBS. DBS fMRI presents a number of technical challenges, including accuracy of electrode implantation, MR artifacts created by the electrode, choice of anesthesia and paralytic to minimize any neuronal effects while simultaneously eliminating animal motion, and maintenance of physiological parameters, deviation from which can confound the BOLD signal. Our laboratory has developed a set of procedures that are capable of overcoming most of these possible issues. For electrical stimulation, a homemade tungsten bipolar microelectrode is used, inserted stereotactically at the stimulation site in the anesthetized subject. In preparation for imaging, rodents are fixed on a plastic headpiece and transferred to the magnet bore. For sedation and paralysis during scanning, a cocktail of dexmedetomidine and pancuronium is continuously infused, along with a minimal dose of isoflurane; this preparation minimizes the BOLD ceiling effect of volatile anesthetics. In this example experiment, stimulation of the subthalamic nucleus (STN) produces BOLD responses which are observed primarily in ipsilateral cortical regions, centered in motor cortex. Simultaneous DBS and fMRI allows the unambiguous modulation of neural circuits dependent on stimulation location and stimulation parameters, and permits observation of neuronal modulations free of regional bias. This technique may be used to explore the downstream effects of modulating neural circuitry at nearly any brain region, with implications for both experimental and clinical DBS.
Determining the global downstream effects of neural circuit activity represents a major challenge and goal for many areas of systems neuroscience. A paucity of tools are currently available that meet this need, and thus there is a demand for increased accessibility of the appropriate experimental setups. One such method for evaluating the global consequence of neural circuit activation relies on the simultaneous application of deep brain electrical stimulation (DBS) and functional MRI (fMRI). DBS-fMRI allows for the detection of downstream responses to circuit activation on a large spatial scale, and can be applied at virtually any stimulation target. This toolset is highly suitable for translational preclinical studies, including the characterization of responses to therapeutic high frequency stimulation.
In addition to access to a suitable MRI scanner, successful DBS-fMRI experiments require consideration of a number of variables, including electrode type, sedation method, and maintenance of physiological parameters. For example, electrode choice should be based on factors relating to stimulation efficacy (e.g. lead size and conductance, mono- vs. bipolar), as well as MR compatibility and electrode artifact size. Electrode artifacts vary according to electrode material and size, as well as the scan sequence used; thorough pre-experimental testing should be employed to determine the appropriate electrode type for each study. In general, tungsten microwire electrodes are recommended for this protocol. Choice of paralytic and sedative should be made to effectively immobilize the animal and reduce the suppressive effects of certain sedatives on blood-oxygen-level-dependent (BOLD) signal. Lastly, it is critical to maintain the animal at optimal physiological parameters, including body temperature and oxygen saturation.
The protocol that we have developed for DBS-fMRI overcomes many of these potential obstacles, and in our hands, provides robust and consistent results. Additionally, these experimental procedures may be readily adopted for the combination of fMRI with alternative stimulation methods, including optogenetic stimulation.
Ethics Statement: This procedure is in accordance with the National Institutes of Health Guidelines for Animal Research (Guide for the Care and Use of Laboratory Animals) and is approved by the University of North Carolina Institutional Animal Care and Use Committee.
1. Electrode Implantation
The first step is electrode implantation. In this step, an electrode is unilaterally implanted into the subthalamic nucleus (STN), a small nucleus with translational significance for Parkinson’s disease treatment using the following methods:
2. fMRI Preparation
The second step is the setup for fMRI, including positioning of the coil and setup of physiological monitoring equipment.
3. fMRI Data Acquistion
The third step is fMRI acquisition, including positioning, shimming, anatomical scans, and functional scans. A 9.4 Tesla system with a homemade surface coil is used here, though this technique may be adapted to other high-field systems and commercially made MRI coils.
4. fMRI Data Processing and Analysis
The fourth step is processing and analysis of fMRI data, including generation of response maps and calculation of percent BOLD signal change. Custom programs running within a computing environment (e.g. MATLAB) or commercial fMRI software tools (e.g. SPM, FSL, or AFNI) may be employed.
Representative functional data were acquired according to the above protocol in a single rat with a stimulating electrode implanted to the subthalamic nucleus on the right side. An illustration of essential setup for DBS fMRI image acquisition is provided in Figure 1. Stimulation was applied consistent with the above protocol, with an amplitude of 0.3 mA, frequency of 130 Hz and pulse width of 0.09 msec. Robust activation of ipsilateral motor cortex has been consistently visualized using this protocol with the subthalamic nucleus as the stimulation target. With a square-wave stimulation pattern, the BOLD signal would be expected to be modulated with respect to the baseline (no-stimulation condition) with a time course correlated to the stimulation period. Here positive BOLD responses are observed in the expected brain region (Figure 2) and with an ON/OFF pattern well-correlated to the stimulation paradigm, taking into account a brief hemodynamic delay (Figure 3). From the map (Figure 2), an overlaid neuroanatomical atlas1 may be used to define precise regions of interest to compare the BOLD effect at individual brain regions. For STN DBS the BOLD response at the motor cortex is shown in Figure 3, though regions of interest may be placed in any brain area. These responses may then be averaged between scans and then between subjects to identify brain regions which produce a consistent response to stimulation. Targeting of other neuroanatomical structures may produce different response patterns than those shown in this experiment. Additionally, even a small degree of inaccuracy in electrode placement may produce large differences in response, as may differences in electrode types and electrical stimulation parameters3.
Figure 1. Scheme of basic fMRI configuration with surface coil, electrode position and stimulator synchronization.
Figure 2. Representative EPI images labeled with correlation coefficients from a single animal, with posterior to anterior slices displayed left to right. Color bar indicates correlation coefficients at each voxel.
Figure 3. Typical % BOLD over time from a single animal averaged over multiple scans at the same stimulation parameters: 0.3 mA, 130 Hz, 0.09 msec pulse width. Yellow bar indicates period of time in which stimulation was applied to the subthalamic nucleus. ROI was within motor cortex. Note: These stimulation parameters are within the standard range for DBS at the STN, but may need to be modified for alternative stimulation sites.
Simultaneous DBS and fMRI represents a promising experimental toolkit for the identification and characterization of global downstream responses to neural circuit stimulation, in vivo. The major advantage of this technique over other available tools, such as electrophysiological recordings, lies in the relatively unbiased nature of fMRI, whereby a large and diverse area of brain tissue can be examined for responsiveness to DBS at any target. Although the described protocol is specific for DBS-fMRI in the rat, neuroimaging of DBS responses has also been successfully conducted in other model organisms, including pigs6.
Perhaps the most obvious application for this technique is the modeling of DBS as applied therapeutically for certain neurological and psychiatric disorders, i.e. Parkinson’s disease7-9. In Parkinson’s disease patients, high frequency stimulation at either the subthalamic nucleus (STN) or internal globus pallidus (GPi) is effective for the alleviation of many motor symptoms10. High frequency DBS at either of these targets results in substantial activation within both canonical motor and limbic areas6. The characterization of these spatially dynamic fMRI responses, when complemented by behavioral analysis, may aid in the identification of therapeutic DBS circuits. The conclusions drawn from such studies should readily translate to the clinic, specifically for the refinement of DBS at existing targets and extension of DBS to new targets for various diseases and disorders.
General limitations of fMRI have been extensively reviewed elsewhere11, although several specific limitations are particularly pertinent to DBS-fMRI. DBS may result in temporally dynamic changes in cellular activity12 that may not be adequately resolved with fMRI. For experiments requiring finer temporal resolution than can currently be offered by fMRI alone, we suggest electrophysiological recordings, which may be acquired in conjunction with fMRI13-15. An additional issue concerns the complex BOLD responses observed in response to neural activity16-21. fMRI allows for the detection of areas modulated by DBS, although caution should be taken when inferring the direction of this modulation based of fMRI data alone. The application of multiple fMRI modalities (e.g. BOLD, cerebral blood flow, cerebral blood volume, functional connectivity, and manganese-enhanced MRI), as well as electrophysiological and histological data, should strengthen such conclusions.
Many of the details provided in this protocol can be readily adopted for alternative stimulation methods, including optogenetic targeting22. For optogenetic experiments, a laser driver can be interfaced with stimulation software to obtain TTL triggering of laser pulses. For such experiments, it is important to use a patch cable of appropriate length so that the optic fiber can be coupled to a laser driver located outside of the scanner room. Opto-fMRI allows for the detection of neurovascular changes induced by selective modulation of activity within genetically defined cell populations, while electrical DBS-fMRI responses cannot be easily attributed to recruitment of specific circuits. Nevertheless, electrical DBS is likely of greater translational value for studying therapeutic DBS, which solely relies on electrical stimulation in patient populations.
Concerns for safety and local tissue damage are important considerations for neuroimaging with simultaneous DBS in both clinical and animal research settings, and have been discussed extensively elsewhere (Carmichael23,24). While many MRI sequences have the potential to cause significant heating and tissue damage, the stimulation parameters and scan sequences in this protocol are designed to minimize these factors, particularly the length of each scan sequence between rest periods. As such, responses to stimulation after dozens of scans are consistently durable in pilot studies, and no signs of local tissue damage are seen on post-mortem imaging, confirming that this protocol is safe with regards to current delivery and MR compatibility of the electrode used.
The flexibility of the described DBS-fMRI procedure, coupled with the wealth of information provided regarding regional modulation profiles in response to DBS, make this procedure ideal for a variety of applications in systems-level neuroscience.
The authors have nothing to disclose.
We thank Shaili Jha and Heather Decot for assistance with filming.
Isoflurane (Forane) | Baxter | 1001936060 | |
Dexmedetomidine (Dexdomitor) | Pfizer | 145108-58-3 | |
Pancuronium Bromide | Selleckchem | S2497 | |
9.4T Small Animal MRI | Bruker | BioSpec System with BGA-9S gradient | |
Sterotactic Frame | Kopf | Model 962 | |
Small Animal Ventilator | CWE, Inc. | 12-02100 | Model SAR-830 |
Dental Cement | A-M Systems | 525000 | Teets Cold Curing |
MouseOx Plus System | STARR Life Science Corp. | ||
Capnometer | Surgivet, Smith Medical | V9004 Series | |
Stimulus Isolator | World Precision Instruments | Model A365 | |
MR-compatible Brass Screws | McMaster Carr | 94070A031 | 0-80 thread size, 1/4 inch. Can be cut to desired length. |
Tungsten Wire | California Fine Wire Company | 100211 | Used to construct MR-compatible stimulating microelectrode |
Syringe Pump | Harvard Appartus | Model PHD 2000 (not MRI-compatible) |